VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Vogenx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 17, 2026
$15.92+1.39 (+9.57%)
Close on Oct 19, 2026
- Market cap
- $86.79M
- P/E (TTM)
- –
- Dividend yield
- –
Vogenx statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Vogenx | Industry median |
|---|---|---|
| Market Cap | $236.49M | $166.30M |
| Enterprise Value | $236.30M | $88.19M |
Balance sheet
| Measure | Vogenx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $193.02K | $61.43M |
| Net Cash (Debt) | $193.02K | $15.35M |
| Net Cash Per Share | $0.01 | $0.66 |
| Equity (Book Value) | -$1.78M | $49.09M |
| Book Value Per Share | -$0.12 | $1.37 |
| Tangible Book Value | -$1.78M | $23.52M |
| Working Capital | -$1.78M | $76.81M |
Financial position
| Measure | Vogenx | Industry median |
|---|---|---|
| Current Ratio | 0.44 | 3.34 |
| Quick Ratio | 0.06 | 2.44 |
Shares
| Measure | Vogenx | Industry median |
|---|---|---|
| Shares Outstanding | 14,855,100 | 58,127,000 |
| Float | 11,608,100 | 49,136,700 |
| Shares Held by Insiders | 21.9% | 11.6% |
Scores
| Measure | Vogenx | Industry median |
|---|---|---|
| Altman Z-Score | 31.36 | -0.22 |
Calculated by StockData from Vogenx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.